Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Veteran's diabetes mellitus type II is rated at 20 percent, but the Board finds that a higher rating is not warranted due to lack of use of insulin or hospitalizations.,The Veteran's bilateral hearing loss does not meet the criteria for a compensable disability rating under VA regulations.,The Veteran has been granted service connection for tinnitus and obstructive sleep apnea. The Board remanded these issues as there are questions about their onset in service.,Service connection was established for hypertension, left knee disability, right knee disability, skin fungus (tinea pedis), and skin cancer (basal cell carcinoma).,The Veteran's gastroesophageal reflux disorder (GERD) is not yet service connected.

The Veteran's claims for service connection were reopened and granted effective October 6, 2015.

The Veteran's claim for service connection for dermatitis is being remanded due to the need for a VA examination.

The Veteran's appeal for an initial compensable rating for allergic rhinitis is denied, and the issue of a higher rating for pseudofolliculitis barbae is remanded due to duty-to-assist error.

The Veteran's claims for increased ratings and service connection were denied. The hypertension claim was denied as the evidence did not meet the criteria for a compensable rating. The dyshidrotic eczema of both hands claim was also denied due to insufficient affected area or systemic therapy.

The Veteran's claim for higher ratings on appeal has been dismissed due to his death. The Board does not have jurisdiction to adjudicate the merits of the claim as he died during the pendency of the appeal.

The Veteran's skin disorder, lichen planus, is granted compensation under 38 U.S.C. § 1151 due to it being caused by VA treatment during a prostate biopsy in December 2012. The issue of service connection for tinnitus and bilateral foot disorders are remanded.

The Veteran's claim for an initial compensable rating for pseudofolliculitis barbae with post-inflammatory hyperpigmentation, including on the bilateral lower extremities, is being remanded due to incomplete examination results.

The Veteran's service-connected acne with hyperpigmentation has not met the criteria for a higher evaluation on or after February 25, 2013. The case is remanded due to inconsistencies in medical evidence and lack of clear entitlement to an increased rating.

The Veteran's claim for a higher rating for his skin condition, pseudofolliculitis barbae (PFB), is being remanded due to the need for further development and examination.

The Board denied service connection for PTSD, dermatitis, and lymphoplasmacytic lymphoma as the evidence did not support a diagnosis of these conditions during or after service.

Effective October 4, 2012, a 50 percent rating for anxiety disorder is granted. A 30 percent rating for hypothyroidism is granted. A 10 percent rating for residuals of TBI with intermittent dizziness is granted. A 10 percent rating for pityrosporum folliculitis is granted.

Service connection is denied for prostate cancer, hypertension, and diabetes mellitus type II. The skin condition claim is remanded.

The Veteran's TBI, epilepsy, and migraines are granted as secondary to service-connected PTSD.,Service connection for a skin condition is denied.

The Veteran's claims for service connection for dizziness, fungal dermatitis, left upper extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and left lower extremity peripheral neuropathy are remanded due to a duty to assist error. A VA examination is required to determine the etiology of these conditions.

The Veteran's claim for service connection for a sleep disorder has been reopened. The initial disability rating for bilateral pes planus with bilateral plantar fasciitis prior to December 8, 2019 is granted at 10 percent. Other claims are remanded.

The Board has determined that the reduction of the Veteran's disability rating for dermatitis and urticaria from 60 to 30 percent, effective January 1, 2020, was proper based on improvement in his condition.

The Board denied service connection for chloracne, finding no evidence of a current disability and noting that the Veteran's STRs did not reflect any skin condition. The Board also found no evidence of chloracne to a degree of 10 percent or more within a year of last exposure to herbicide agents.

The Board has denied an increased evaluation for tinea cruris and remanded the issue of service connection for asbestosis. The case is being returned to the July 2020 examiner for a determination on whether any identified pulmonary/respiratory disability, including asbestosis, is related to service.

The Board has remanded the Veteran's claims for additional development, including obtaining updated VA treatment records and scheduling examinations to assess his eczema and keloid scars. The GERD claim is also referred to the Director of Compensation Service for extraschedular consideration.